Korean Stock Flows

Bio Plus (KRX: 099430)

바이오플러스 KOSDAQ Biotech & Pharma 기초 의약물질 제조업
Close (Oct 13, 2026)
₩3,645
-1.22%
Market cap
₩0T ($0.2B)
52-week range
₩3,065 – ₩6,750
P/E (trailing) · P/B · Div yield
14.41 · 1.28 · 1.92%

Who is buying Bio Plus?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net sold ₩0.5bn ($0M) of Bio Plus, the 356th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net sold ₩0.2bn ($0M) and retail investors net sold ₩0.4bn ($0M) over the same window. Foreigners were net buyers on 5 of the 20 sessions.

Foreign investors hold 2.85% of Bio Plus' listed shares (KRX ownership data as of Oct 13, 2026), down from 3.1% twenty sessions earlier and 2.55% a year ago.

The stock closed at ₩3,645 on Oct 13, 2026: +9.46% over 20 sessions, -27.53% year-to-date, -44.01% over one year. The 52-week range is ₩3,065 – ₩6,750.

At ₩3,645 the stock trades at 14.41× trailing earnings (KRX, last completed fiscal year); no analyst consensus is available for a forward P/E.

Bio Plus share price, last 60 trading days (KRW)
3,931 3,675 3,420 3,164 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+0.7bn +0.3bn -0.3bn -0.7bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩3,645 ₩-0.0bn ₩-0.0bn ₩-0.1bn
2026-10-12 ₩3,690 ₩-0.0bn +₩0.0bn ₩-0.1bn
2026-10-08 ₩3,840 ₩-0.1bn +₩0.0bn ₩-0.0bn
2026-10-07 ₩3,870 ₩-0.1bn ₩-0.0bn ₩-0.0bn
2026-10-06 ₩3,785 ₩-0.2bn ₩0.0bn +₩0.1bn
2026-10-02 ₩3,785 ₩-0.1bn ₩-0.0bn ₩-0.1bn
2026-10-01 ₩3,735 +₩0.0bn +₩0.0bn ₩-0.3bn
2026-09-30 ₩3,570 ₩-0.0bn ₩-0.0bn ₩-0.2bn
2026-09-29 ₩3,320 ₩-0.1bn ₩-0.0bn +₩0.0bn
2026-09-28 ₩3,310 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-23 ₩3,285 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-22 ₩3,305 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-09-21 ₩3,315 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-09-18 ₩3,350 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-17 ₩3,310 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-16 ₩3,260 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-09-15 ₩3,205 ₩-0.0bn +₩0.0bn +₩0.1bn
2026-09-14 ₩3,220 +₩0.1bn +₩0.0bn ₩-0.0bn
2026-09-11 ₩3,220 +₩0.1bn ₩-0.1bn +₩0.0bn
2026-09-10 ₩3,220 +₩0.1bn ₩-0.2bn +₩0.2bn
2026-09-09 ₩3,330 ₩-0.0bn +₩0.0bn +₩0.1bn
2026-09-08 ₩3,335 ₩-0.1bn ₩-0.0bn +₩0.2bn
2026-09-07 ₩3,390 +₩0.0bn ₩0.0bn +₩0.0bn
2026-09-04 ₩3,370 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-03 ₩3,300 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-02 ₩3,330 ₩-0.1bn ₩-0.0bn +₩0.2bn
2026-09-01 ₩3,430 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-31 ₩3,450 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-28 ₩3,470 +₩0.1bn +₩0.0bn ₩-0.0bn
2026-08-27 ₩3,430 ₩-0.1bn +₩0.0bn +₩0.2bn
2026-08-26 ₩3,450 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-25 ₩3,455 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-24 ₩3,405 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-08-21 ₩3,375 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-08-20 ₩3,475 ₩-0.1bn ₩0.0bn +₩0.3bn
2026-08-19 ₩3,480 ₩-0.7bn ₩-0.0bn +₩1.0bn
2026-08-18 ₩3,735 ₩-0.0bn +₩0.0bn +₩0.2bn
2026-08-14 ₩3,655 ₩-0.2bn +₩0.0bn +₩0.6bn
2026-08-13 ₩3,610 ₩-0.4bn ₩-0.0bn +₩0.7bn
2026-08-12 ₩3,720 ₩-0.2bn ₩-0.0bn +₩0.4bn
2026-08-11 ₩3,730 +₩0.1bn ₩-0.0bn +₩0.2bn
2026-08-10 ₩3,720 +₩0.3bn ₩-0.0bn ₩-0.0bn
2026-08-07 ₩3,645 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-06 ₩3,655 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-08-05 ₩3,660 +₩0.1bn ₩-0.0bn +₩0.1bn
2026-08-04 ₩3,635 +₩0.2bn ₩-0.0bn ₩-0.0bn
2026-08-03 ₩3,525 +₩0.2bn ₩-0.0bn ₩-0.1bn
2026-07-31 ₩3,525 +₩0.3bn +₩0.0bn ₩-0.2bn
2026-07-30 ₩3,310 +₩0.3bn ₩0.0bn ₩-0.3bn
2026-07-29 ₩3,320 +₩0.2bn ₩-0.1bn ₩-0.1bn
2026-07-28 ₩3,515 ₩-0.1bn ₩-0.1bn +₩0.2bn
2026-07-27 ₩3,635 +₩0.0bn ₩-0.1bn +₩0.1bn
2026-07-24 ₩3,590 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-23 ₩3,680 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-07-22 ₩3,510 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-07-21 ₩3,605 +₩0.0bn ₩-0.1bn +₩0.0bn
2026-07-20 ₩3,610 +₩0.0bn ₩-0.1bn +₩0.0bn
2026-07-16 ₩3,805 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-07-15 ₩3,850 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-07-14 ₩3,760 ₩-0.1bn ₩0.0bn +₩0.2bn
2026-07-13 ₩3,890 ₩-0.3bn ₩-0.0bn +₩0.4bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day ₩-0.0bn $-0M ₩-0.0bn ₩-0.1bn
5 days ₩-0.4bn $-0M ₩-0.0bn ₩-0.2bn
20 days ₩-0.5bn $-0M ₩-0.2bn ₩-0.4bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Bio Plus stock?

Over the last 5 sessions foreign investors net sold ₩0.4bn ($0M) of Bio Plus; over 60 sessions they net sold ₩0.4bn ($0M); since Jan 1, 2026 they net bought ₩4.9bn ($4M). Over 20 sessions the stock is the 356th largest foreign net sale among 1828 KOSDAQ stocks.

How much of Bio Plus do foreign investors own?

Foreign investors own 2.85% of Bio Plus' shares as of Oct 13, 2026, versus 2.55% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩0.2bn ($0M) and retail investors net sold ₩0.4bn ($0M) of Bio Plus. No single investor group dominates the flow in this window.

Is Bio Plus listed on KOSPI or KOSDAQ?

Bio Plus (바이오플러스) trades on KOSDAQ under KRX code 099430 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩65bn ($49M) – ₩28bn ($21M) ₩27bn ($21M)
2024 ₩66bn ($50M) +2.10% ₩24bn ($18M) ₩18bn ($13M)
2025 ₩91bn ($68M) +36.90% ₩15bn ($11M) ₩20bn ($15M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows